Skip to main content

Complex Commercial Litigation

Viewpoints

Filter by:

Complex Commercial Litigation Viewpoints Thumbnail
This alert reviews executive orders by New York Governor Cuomo and administrative orders by the New York State courts that have stayed residential and commercial evictions and foreclosures in New York.
Read more
Complex Commercial Litigation Viewpoints Thumbnail

What the COVID-19 Pandemic Means for Force Majeure Provisions

March 13, 2020 | Alert | By Samuel M. Tony Starr, Alyssa B. Roy, Kaitlyn C. Leonard, Clare Prober

Read about what the World Health Organization’s declaration that COVID-19 is a pandemic means for force majeure provisions in contracts.
Read more
Complex Commercial Litigation Viewpoints Thumbnail

What You Need to Know about Force Majeure in Light of the Coronavirus

March 10, 2020 | Alert | By Samuel M. Tony Starr, Kaitlyn C. Leonard, Clare Prober

With the outbreak of coronavirus disease 2019 (“COVID-19”), the disease caused by the novel coronavirus (“SARS-CoV-2”), companies across various industries are taking precautions, some of which already have, and inevitably will result in nonperformance of their contracts.
Read more
Viewpoint Thumbnail

Private Equity Opportunity in Litigation Financing

April 18, 2018 | Alert | By Scott Ford, Kurt Steinkrauss

Litigation financing has quickly grown from a fledging concept into a robust industry. The concept is simple: in exchange for a share of any proceeds, a financing firm agrees to pay all or a portion of the plaintiff’s legal fees.
Read more
Viewpoint Thumbnail

Issuers Face Changing Litigation Landscape, Challenges Due to Supreme Court Ruling

March 22, 2018 | Alert | By Adam Sisitsky, John Sylvia

In a boon for public company shareholder plaintiffs this week, the U.S. Supreme Court upheld state courts’ concurrent jurisdiction over securities class actions alleging violations of certain federal securities laws.
Read more
Viewpoint Thumbnail
Today, the Massachusetts Supreme Judicial Court made an important ruling concerning innovator liability with respect to pharmaceuticals. Though precluding negligence and traditional product liability claims against brand-name manufacturers, Chief Justice Gants held that claims alleging intentional, reckless conduct are permitted.
Read more
Sign up to receive email updates from Mintz.
Subscribe Now

Explore Other Viewpoints: